Mark Weinreb
Plus aucun poste en cours
Profil
Mark Weinreb formerly worked at Big City Bagels, Inc., as Chairman & Chief Executive Officer from 1992 to 1999, BioRestorative Therapies, Inc., as Chairman & Chief Executive Officer from 2011 to 2012, Jestertek, Inc., as Chief Executive Officer from 2000 to 2002, NeoStem, Inc., as President & Director from 2006 to 2009, Phase III Medical, Inc., as President from 2003 to 2006, Caladrius Biosciences, Inc., as President from 2003 to 2009, and Bio-Health Laboratories, Inc., as Chief Operating Officer & Owner from 1976 to 1989.
Mr. Weinreb received his undergraduate degree in 1975 from Northwestern University and graduate degree in 1982 from Long Island University.
Anciens postes connus de Mark Weinreb
| Sociétés | Poste | Fin |
|---|---|---|
| BIORESTORATIVE THERAPIES, INC. | Directeur Général | 16/11/2020 |
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | President | 02/10/2009 |
| NeoStem, Inc. /Old/ | President | 01/10/2009 |
| Phase III Medical, Inc. | Directeur Général | - |
| Jestertek, Inc. | Directeur Général | 01/01/2002 |
Formation de Mark Weinreb
| Northwestern University | Undergraduate Degree |
| Long Island University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIORESTORATIVE THERAPIES, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
| Phase III Medical, Inc. | Finance |
| Big City Bagels, Inc. | Retail Trade |
| NeoStem, Inc. /Old/ | Transportation |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |
| Jestertek, Inc. | |
Bio-Health Laboratories, Inc.
 Bio-Health Laboratories, Inc. Medical/Nursing ServicesHealth Services Bio-Health Laboratories, Inc. operates diagnostic laboratory services. The private company is based in New York. | Health Services |